Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose( )

Mostrar otras versiones (1)

BACKGROUND: Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly recommended, but immunogenicity data remain limited, particularly in older adults. METHODS: We measured circulating antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwimanzi, Francis, Lapointe, Hope R, Cheung, Peter K, Sang, Yurou, Yaseen, Fatima, Umviligihozo, Gisele, Kalikawe, Rebecca, Datwani, Sneha, Omondi, F Harrison, Burns, Laura, Young, Landon, Leung, Victor, Agafitei, Olga, Ennis, Siobhan, Dong, Winnie, Basra, Simran, Lim, Li Yi, Ng, Kurtis, Pantophlet, Ralph, Brumme, Chanson J, Montaner, Julio S G, Prystajecky, Natalie, Lowe, Christopher F, DeMarco, Mari L, Holmes, Daniel T, Simons, Janet, Niikura, Masahiro, Romney, Marc G, Brumme, Zabrina L, Brockman, Mark A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129202/
https://www.ncbi.nlm.nih.gov/pubmed/35543278
http://dx.doi.org/10.1093/infdis/jiac199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129202/
https://www.ncbi.nlm.nih.gov/pubmed/35543278
http://dx.doi.org/10.1093/infdis/jiac199

Ejemplares similares